Literature DB >> 33896471

Opioids in Hemodialysis Patients.

Sahir Kalim1, Karen S Lyons2, Sagar U Nigwekar3.   

Abstract

Chronic pain and prescription opioid use are prevalent among patients with end-stage kidney disease treated with hemodialysis. Vulnerabilities to complications from opioid use are high in this patient population, as shown in many recent, well-conducted, patient-oriented studies. Such studies have highlighted the need for a balanced approach to pain management in hemodialysis patients that includes careful assessment of the risks and benefits of opioid prescriptions in this population. In this article, we review the available literature and experience regarding opioid prescriptions among hemodialysis patients, discuss clinical implications, and outline ongoing research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buprenorphine; hemodialysis; hydrocodone; methadone; morphine; opioid; oxycodone; pain

Mesh:

Substances:

Year:  2021        PMID: 33896471      PMCID: PMC8083988          DOI: 10.1016/j.semnephrol.2021.02.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  60 in total

Review 1.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

2.  Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-04       Impact factor: 8.237

Review 3.  Laboratory testing for prescription opioids.

Authors:  Michael C Milone
Journal:  J Med Toxicol       Date:  2012-12

4.  Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.

Authors:  Salina P Waddy; Adan Z Becerra; Julia B Ward; Kevin E Chan; Chyng-Wen Fwu; Paul W Eggers; Kevin C Abbott; Paul L Kimmel
Journal:  Am J Nephrol       Date:  2020-05-19       Impact factor: 3.754

5.  Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.

Authors:  Boaz Gedaliahu Samolsky Dekel; Gabriele Donati; Alessio Vasarri; Anna Laura Croci Chiocchini; Alberto Gori; Giuseppe Cavallari; Gianfranco Di Nino; Laura Mercolini; Michele Protti; Roberto Mandrioli; Rita Maria Melotti; Gaetano La Manna
Journal:  Pain Pract       Date:  2016-09-02       Impact factor: 3.183

6.  Falls among hemodialysis patients: potential opportunities for prevention?

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Haimanot Wasse
Journal:  Clin Kidney J       Date:  2014-04-15

7.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.

Authors:  Lynn R Webster; Rebecca M Webster
Journal:  Pain Med       Date:  2005 Nov-Dec       Impact factor: 3.750

8.  Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients.

Authors:  Steven D Weisbord; Linda F Fried; Robert M Arnold; Michael J Fine; David J Levenson; Rolf A Peterson; Galen E Switzer
Journal:  J Am Soc Nephrol       Date:  2005-06-23       Impact factor: 10.121

9.  The three-year incidence of fracture in chronic kidney disease.

Authors:  Kyla L Naylor; Eric McArthur; William D Leslie; Lisa-Ann Fraser; Sophie A Jamal; Suzanne M Cadarette; Jennie G Pouget; Charmaine E Lok; Anthony B Hodsman; Jonathan D Adachi; Amit X Garg
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

10.  The role of endogenous opioids in the baroreflex dysfunction of dialysis patients.

Authors:  C Zoccali; M Ciccarelli; F Mallamaci; Q Maggiore; M Stornello; E Valvo; L Scapellato
Journal:  Proc Eur Dial Transplant Assoc Eur Ren Assoc       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.